Literature DB >> 32480433

Human neutrophils activated by TLR8 agonists, with or without IFNγ, synthesize and release EBI3, but not IL-12, IL-27, IL-35, or IL-39.

Marco A Cassatella1, Elisa Gardiman1, Fabio Arruda-Silva1, Francisco Bianchetto-Aguilera1, Sara Gasperini1, Mattia Bugatti2, William Vermi2,3, Frederique Larousserie4,5, Odile Devergne4, Nicola Tamassia1.   

Abstract

The IL-12 family of cytokines plays crucial functions in innate and adaptive immunity. These cytokines include heterodimers sharing distinct α (IL-12A, IL-23A, and IL-27A) with two β (IL-12B and Epstein-Barr virus induced gene 3 [EBI3]) chains, respectively, IL-12 (IL-12B plus IL-12A) and IL-23 (IL-12B plus IL-23A) sharing IL-12B, IL-27 (EBI3 plus IL-27A), IL-35 (EBI3 plus IL-12A), and IL-39 (EBI3 plus IL-23A) sharing EBI3. In this context, we have recently reported that highly pure neutrophils incubated with TLR8 agonists produce functional IL-23. Previously, we showed that neutrophils incubated with LPS plus IFNγ for 20 h produce IL-12. Herein, we investigated whether highly pure, TLR8-activated, neutrophils produce EBI3, and in turn IL-27, IL-35, and IL-39, the IL-12 members containing it. We report that neutrophils incubated with TLR8 ligands, TNFα and, to a lesser extent, LPS, produce and release remarkable amounts of EBI3, but not IL-27A, consequently excluding the possibility for an IL-27 production. We also report a series of unsuccessful experiments performed to investigate whether neutrophil-derived EBI3 associates with IL-23A to form IL-39. Furthermore, we show that neutrophils incubated with IFNγ in combination with either TLR8 or TLR4 ligands express/produce neither IL-12, nor IL-35, due to the inability of IFNγ, contrary to previous findings, to activate IL12A transcription. Even IL-27 was undetectable in supernatants harvested from IFNγ plus R848-treated neutrophils, although they were found to accumulate IL27A transcripts. Finally, by immunohistochemistry experiments, EBI3-positive neutrophils were found in discrete pathologies only, including diverticulitis, cholecystitis, Gorham disease, and Bartonella Henselae infection, implying a specific role of neutrophil-derived EBI3 in vivo. ©2020 Society for Leukocyte Biology.

Entities:  

Keywords:  EBI3; IL-12; IL-27; IL-35; Neutrophils; TLR8; TNFα

Mesh:

Substances:

Year:  2020        PMID: 32480433     DOI: 10.1002/JLB.3MA0520-054R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  6 in total

Review 1.  Interleukin-35: Structure, Function and Its Impact on Immune-Related Diseases.

Authors:  Cheng Ye; Hiroshi Yano; Creg J Workman; Dario A A Vignali
Journal:  J Interferon Cytokine Res       Date:  2021-11       Impact factor: 2.607

2.  Lack of evidence for expression and function of IL-39 in human immune cells.

Authors:  Florence Ecoeur; Jessica Weiss; Simone Schleeger; Christine Guntermann
Journal:  PLoS One       Date:  2020-12-01       Impact factor: 3.240

3.  Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16- subset.

Authors:  Irene Veneziani; Claudia Alicata; Andrea Pelosi; Nadine Landolina; Biancamaria Ricci; Valentina D'Oria; Anna Fagotti; Giovanni Scambia; Lorenzo Moretta; Enrico Maggi
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 13.751

4.  Immunomodulatory effects of new phytotherapy on human macrophages and TLR4- and TLR7/8-mediated viral-like inflammation in mice.

Authors:  Olesia Schapovalova; Anna Gorlova; Johannes de Munter; Elisaveta Sheveleva; Mikhail Eropkin; Nikita Gorbunov; Michail Sicker; Aleksei Umriukhin; Sergiy Lyubchyk; Klaus-Peter Lesch; Tatyana Strekalova; Careen A Schroeter
Journal:  Front Med (Lausanne)       Date:  2022-08-22

5.  Epigenetic DNA Methylation of EBI3 Modulates Human Interleukin-35 Formation via NFkB Signaling: A Promising Therapeutic Option in Ulcerative Colitis.

Authors:  Alexandra Wetzel; Bettina Scholtka; Fabian Schumacher; Harshadrai Rawel; Birte Geisendörfer; Burkhard Kleuser
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

Review 6.  A Chaperone-Like Role for EBI3 in Collaboration With Calnexin Under Inflammatory Conditions.

Authors:  Aruma Watanabe; Izuru Mizoguchi; Hideaki Hasegawa; Yasuhiro Katahira; Shinya Inoue; Eri Sakamoto; Yuma Furusaka; Ami Sekine; Satomi Miyakawa; Fumihiro Murakami; Mingli Xu; Toshihiko Yoneto; Takayuki Yoshimoto
Journal:  Front Immunol       Date:  2021-09-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.